Study offers hope for patients with advanced cervical cancer
2/25/2014
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine. The multi-site research project by Bradley J. Monk, MD, is expected to change the standard of care for women with advanced cervical cancer.
Now indication and hint of major added benefit for patients with metastatic prostate cancerEnzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.
Study offers hope for patients with advanced cervical cancer
2/25/2014
Research on cervical cancer performed by a physician at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center has been published in the New England Journal of Medicine. The multi-site research project by Bradley J. Monk, MD, is expected to change the standard of care for women with advanced cervical cancer.
Increased risk of prostate cancer in some men taking selenium and vitamin E supplements
2/25/2014
A multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man's selenium status before taking the supplements.
Researchers enhance anti-cancer benefits, increase shelf life of broccoli
2/25/2014
While researching methods to increase the already well-recognized anti-cancer properties of broccoli, researchers at the University of Illinois also found a way to prolong the vegetable's shelf life.
Chemotherapy enhanced by preventing cell repair in tumour cells
2/25/2014
Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy of chemotherapy. Blocking the mechanisms for DNA repair would help to potentiate chemotherapy by reducing the resistance of cells to treatment.
Chronic illness, already a major and expensive problem in developed countries, is rapidly increasing in developing countries, adding to the longstanding burden caused by high rates of infectious diseases.
Study of cell behaviour in low oxygen conditions has important implications for tumours
2/25/2014
Research at the University of Liverpool has explained how cells behave when placed in a low oxygen environment, a development that could have implications for cancer patients and other serious illnesses.The research opens up the possibility of controlling the signals that keep cells alive, preventing the damages caused by ischemia - a restriction of blood supply to tissues.
Increased risk of prostate cancer in some men taking selenium and vitamin E supplements
2/25/2014
A multi-center study led by Fred Hutchinson Cancer Research Center has found that high-dose supplementation with both the trace element selenium and vitamin E increase the risk of high-grade prostate cancer. But importantly, this risk depends upon a man's selenium status before taking the supplements.
Chemotherapy enhanced by preventing cell repair in tumour cells
2/25/2014
Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy of chemotherapy. Blocking the mechanisms for DNA repair would help to potentiate chemotherapy by reducing the resistance of cells to treatment.